Total n=279 (%) | ACE ≥4 n=78 (%) | P value* | |
Gender | |||
Male | 189 (68) | 49 (26) | 0.273 |
Female | 90 (32) | 29 (32) | |
Age group (years) | |||
0 to <5 | 180 (65) | 34 (19) | <0.001 |
5 to <10 | 68 (24) | 24 (35) | |
≥10 | 31 (11) | 20 (65) | |
Cultural background | <0.001 | ||
Asian | 54 (19) | 7 (13) | |
Middle Eastern | 51 (18) | 8 (16) | |
Anglo-Australian | 44 (16) | 24 (55) | |
Indigenous | 33 (12) | 21 (64) | |
Other | 40 (14) | 8 (20) | |
Unknown | 57 (21) | 10 (18) | |
Clinical conditions | |||
Primary diagnosis | 274 (98) | 77 (28) | NA |
Secondary diagnosis | 224 (80) | 59 (26) | 0.224 |
Existing chronic conditions | 163 (58) | 40 (25) | 0.132 |
Chronic conditions ≥2 | 79 (28) | 20 (25) | 0.537 |
A child could have one or more diagnoses as well as a chronic condition; or one diagnosis with a chronic condition.
NA denotes χ2 test not carried out as more than 1 expected cell count <5.
*P value comparing ACE ≥4 group and different clinical/demographic categories.
ACE, adverse childhood experience; CP, community paediatric.